PIEZO1 and cancer: In tumor cells, Piezo1-mediated Ca2+ signaling promotes cytoskeletal remodeling, epithelial–mesenchymal transition, YAP/TAZ activation, and angiogenesis; concomitantly, Piezo1 drives cancer-associated fibroblast activation and ECM remodeling, collectively reinforcing invasion and therapy resistance.